SGHT Q4 2024 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+1.7% YoY

Gross Profit

$17M86.8% margin

Operating Income

-$12M-62.5% margin

Net Income

-$12M-62.1% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-5.4%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$143M

Total Liabilities

$55M

Stockholders' Equity

$88M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$19M	+1.7%
Gross Profit	$17M	$16M	+3.7%
Operating Income	-$12M	-$11M	-7.4%
Net Income	-$12M	-$11M	-10.8%

Revenue Segments

Surgical Glaucoma

$19M98%

Dry Eye

$305,0002%